Deals In Depth: August 2015
Executive Summary
Following their asset swap last year, GSK handed over to Novartis complete ownership of the CD20 antagonist ofatumumab; Greatbatch acquired privately held Lake Region Medical Holdings for $1.74 billion in cash and stock. Biopharma financing decreased while device fundraising jumped.